703
Views
4
CrossRef citations to date
0
Altmetric
Review

Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapy

, , &
Pages 423-435 | Received 02 Feb 2018, Accepted 20 Mar 2018, Published online: 27 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Shahrzad Sepehrirad, Arash Amanlou, Kowsar Bagherzadeh, Homa Azizian & Massoud Amanlou. (2021) Library-based lead compound discovery for CS-1 protein in multiple myeloma: homology modelling, molecular dynamic simulations, virtual screening and molecular docking. Molecular Simulation 47:16, pages 1358-1371.
Read now
Pellegrino Musto & Francesco La Rocca. (2020) Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence. Expert Review of Hematology 13:5, pages 501-517.
Read now
Pellegrino Musto & Francesco La Rocca. (2020) Monoclonal antibodies in relapsed/refractory myeloma: updated evidence from clinical trials, real-life studies, and meta-analyses. Expert Review of Hematology 13:4, pages 331-349.
Read now
Johannes Nelke, Juliane Medler, Daniela Weisenberger, Andreas Beilhack & Harald Wajant. (2020) CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism. mAbs 12:1.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.